Biorelevant Dissolution Testing
Biorelevant Dissolution Testing is an in vitro dissolution testing methodology that employs physiologically representative media and experimental conditions that mimic the gastrointestinal environment in order to predict the in vivo dissolution behavior and intraluminal performance of orally administered drug products.
151
Publications
6.4K
Citations
670
Authors
200
Institutions
Publications per year
2017–2026
65
Parents
151
Maria Vertzoni, Nikoletta Fotaki, Eleftheria Nicolaides et al. · Journal of Pharmacy and Pharmacology · 2004 · 236 citations · Full text
Pharmacy, Biochemistry, Pharmacology +17
Vibeke Hougaard Sunesen, Betty Lomstein Pedersen, Henning Gjelstrup Kristensen et al. · European Journal of Pharmaceutical Sciences · 2005 · 169 citations
1–5 of 151
670
26
h-index
12
h-index
National and Kapodistrian University of Athens, Greece
11 publications · 1.1K citations
11
h-index
11
h-index
8
h-index
1–5 of 670
200
Goethe University Frankfurt
Frankfurt am Main, Germany
26 h-index
65 publications
5.1K citations
Universität Greifswald
Greifswald, Germany
13 h-index
35 publications
925 citations

National and Kapodistrian University of Athens
Athens, Greece
12 h-index
31 publications
3.1K citations
Bayer (Germany)
Leverkusen, Germany
8 h-index
12 publications
449 citations
KU Leuven
Leuven, Belgium
7 h-index
22 publications
993 citations
Boehringer Ingelheim (Germany)
Ingelheim, Germany
6 h-index
11 publications
769 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
6 h-index
9 publications
334 citations
University of Copenhagen
Copenhagen, Denmark
6 h-index
22 publications
1.3K citations
1–8 of 200
EJPB · 16 publications · 832 citations
16
h-index
17 publications · 646 citations
15
h-index
16 publications · 529 citations
15
h-index
16 publications · 889 citations
14
h-index
15 publications · 668 citations
12
h-index
1–5